11/14
02:35 pm
nvct
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug [Yahoo! Finance]
Medium
Report
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug [Yahoo! Finance]
11/14
07:09 am
nvct
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer [Yahoo! Finance]
High
Report
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer [Yahoo! Finance]
11/14
07:00 am
nvct
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer
High
Report
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer
11/5
10:30 am
nvct
Nuvectis Pharma GAAP EPS of -$0.24 beats by $0.01 [Seeking Alpha]
High
Report
Nuvectis Pharma GAAP EPS of -$0.24 beats by $0.01 [Seeking Alpha]
11/5
07:00 am
nvct
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
High
Report
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
10/28
08:24 am
nvct
PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update [Yahoo! Finance]
High
Report
PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update [Yahoo! Finance]
10/28
08:21 am
nvct
PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update
High
Report
PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update
10/23
08:00 am
nvct
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics
Low
Report
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics
10/7
08:00 am
nvct
Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Low
Report
Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
9/24
07:30 am
nvct
Here's Why We're Watching Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation [Yahoo! Finance]
Low
Report
Here's Why We're Watching Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation [Yahoo! Finance]
9/16
07:15 am
nvct
PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch
Medium
Report
PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch
9/5
08:00 am
nvct
Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference
8/30
07:10 am
nvct
Nuvectis' NXP800 gains FDA ODD for cancer treatment [Yahoo! Finance]
Low
Report
Nuvectis' NXP800 gains FDA ODD for cancer treatment [Yahoo! Finance]
8/29
08:00 am
nvct
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
High
Report
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
8/28
07:37 am
nvct
Positive Signs As Multiple Insiders Buy Nuvectis Pharma Stock [Yahoo! Finance]
Low
Report
Positive Signs As Multiple Insiders Buy Nuvectis Pharma Stock [Yahoo! Finance]